The global elemental analysis market size is expected to reach USD 2.70 billion by 2030, registering a CAGR of 6.4% during the forecast period, according to a new report by Grand View Research, Inc. The market is primarily driven by amendments in the ICH (International Council for Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use) regulations that mandate use of elemental analysis for finished medical products, including pharmaceuticals.
Many manufacturers of elemental analyzers invest in R&D of new and technologically advanced products. In addition to their expenses for R&D, many key players launched new products in the market. For instance, in May 2016, Agilent Technologies launched Agilent 5110 ICP-OES, which was designed to enable scientists perform fast and precise elemental analysis of pharmaceuticals and food products along with mining, industrial, and environmental analysis.
In addition, in many countries, the limit of heavy metals/trace elements is regulated by their respective pharmacopeias. For instance, United States, Japanese, and European pharmacopeias limit the amount of trace elements in finished pharmaceutical products. Furthermore, elemental analysis is a crucial step before commercial launch of a medical product in the market.
North America held the largest market share in 2023. Local presence of large number of manufacturers, regulation of limits of trace elements/heavy metals by United States Pharmacopeia (USP), and ongoing research for development of new products are major factors responsible for the largest share held by this region. However, Asia Pacific is likely to grow at the highest rate over the forecasts period. Rise in interest of market players to expand their business in Asia Pacific, growing awareness on safety of pharmaceuticals, and increase in expenditure by local pharmaceutical companies on elemental analyzers are factors that can be attributed for the highest growth rate of Asia Pacific region during the forecast period.
Request a free sample copy or view report summary: Elemental Analysis Market Report
The inorganic elements segment held the largest revenue share in 2023 due upcoming mandates for elemental analysis in medical products
By technology, non-destructive technologies held the largest revenue share of the market in 2023. Retention of sample after analysis and high precision rate can be the key factors for largest share of this segment
North America dominated the global elemental analysis market due to presence of USP regulations that limit the amount of heavy metals/trace elements.
Grand View Research has segmented the global elemental analysis market based on element, technology, end-use, and region:
Elemental Analysis Element Outlook (Revenue, USD Million, 2018 - 2030)
Organic
Inorganic
Elemental Analysis Technology Outlook (Revenue, USD Million, 2018 - 2030)
Destructive Technologies
ICP-MS
ICP-OES
Combustion Analysis
Other Destructive Technologies
Non-Destructive Technologies
XRF
FTIR
Other Nondestructive Technologies
Elemental Analysis End-use Outlook (Revenue, USD Million, 2018 - 2030)
Academic Research
Pharma & Biotech Entities
Others
Elemental Analysis Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
Saudi Arabia
UAE
South Africa
Kuwait
List of Key Players in the Elemental Analysis Market
AMETEK.Inc.
HORIBA Ltd.
Shimadzu Corporation.
Analytik Jena GmbH+Co.
ELEMENTAR
PerkinElmer Inc.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Danaher Corporation
Rigaku Corporation
"The quality of research they have done for us has been excellent..."